US-China Biomedical Technology Inc - ESG Rating & Company Profile powered by AI
Alternative corporations in the scoring peer group for US-China Biomedical Technology Inc are shown below. The webpage of US-China Biomedical Technology Inc was assembled by All Street Sevva using cutting edge machine learning. The page displays a zero-cost E,S&G assessment for US-China Biomedical Technology Inc.
US-China Biomedical Technology Inc in the IT Services & Consulting industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | CES Ltd | 8.0 | High |
1 | Capgemini Technology Services India Ltd | 8.0 | High |
... | ... | ... | |
656 | Solera Holdings Inc | 0.4 | Low |
662 | CoStar Group Inc | 0.3 | Low |
663 | US-China Biomedical Technology Inc | 0.0 | Low |
663 | CR Ventures AB | 0.0 | Low |
663 | CS Loxinfo PCL | 0.0 | Low |
663 | transtec AG | 0.0 | Low |
663 | uVuMobile Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does US-China Biomedical Technology Inc have an accelerator or VC vehicle to help deliver innovation?
Does US-China Biomedical Technology Inc disclose current and historical energy intensity?
Does US-China Biomedical Technology Inc report the average age of the workforce?
Does US-China Biomedical Technology Inc reference operational or capital allocation in relation to climate change?
Does US-China Biomedical Technology Inc disclose its ethnicity pay gap?
Does US-China Biomedical Technology Inc disclose cybersecurity risks?
Does US-China Biomedical Technology Inc offer flexible work?
Does US-China Biomedical Technology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does US-China Biomedical Technology Inc disclose the number of employees in R&D functions?
Does US-China Biomedical Technology Inc conduct supply chain audits?
Does US-China Biomedical Technology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does US-China Biomedical Technology Inc conduct 360 degree staff reviews?
Does US-China Biomedical Technology Inc disclose the individual responsible for D&I?
Does US-China Biomedical Technology Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does US-China Biomedical Technology Inc disclose current and / or historical scope 2 emissions?
Does US-China Biomedical Technology Inc disclose water use targets?
Does US-China Biomedical Technology Inc have careers partnerships with academic institutions?
Did US-China Biomedical Technology Inc have a product recall in the last two years?
Does US-China Biomedical Technology Inc disclose incidents of discrimination?
Does US-China Biomedical Technology Inc allow for Work Councils/Collective Agreements to be formed?
Has US-China Biomedical Technology Inc issued a profit warning in the past 24 months?
Does US-China Biomedical Technology Inc disclose parental leave metrics?
Does US-China Biomedical Technology Inc disclose climate scenario or pathway analysis?
Does US-China Biomedical Technology Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does US-China Biomedical Technology Inc disclose the pay ratio of women to men?
Does US-China Biomedical Technology Inc support suppliers with sustainability related research and development?
Does US-China Biomedical Technology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does US-China Biomedical Technology Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is US-China Biomedical Technology Inc involved in embryonic stem cell research?
Does US-China Biomedical Technology Inc disclose GHG and Air Emissions intensity?
Does US-China Biomedical Technology Inc disclose its waste policy?
Does US-China Biomedical Technology Inc report according to TCFD requirements?
Does US-China Biomedical Technology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does US-China Biomedical Technology Inc disclose energy use targets?
Does US-China Biomedical Technology Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does US-China Biomedical Technology Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for US-China Biomedical Technology Inc
These potential risks are based on the size, segment and geographies of the company.